Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -125.00%. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.04 per share when it actually produced a loss of $0.05, delivering a surprise of -25% ...